| Business Summary | | Westaim
Corporation
is
a
technology
accelerator
that
ensures
its
technology
investments
have
the
leadership,
strategy,
and
capital
to
get
into
the
marketplace
as
quickly
as
possible.
Currently,
Westaim
has
technology
investments
in
the
following
three
sectors
of
the
economy:
biomedical
(Westaim
Biomedical
Corp.),
semi-conductor/electronics
(iFire
Technology,
Inc.),
and
e-business
software
(Savvion).
Westaim
also
has
two
industrial
technologies
businesses,
Surface
Engineered
Products
Corp.
and
Aerospace
Materials,
and
two
industrial
businesses
that
produce
coin
blanks
and
chemicals. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | WEDX
operates
in
two
high
technology
businesses:
iFre
Technology,
Westaim
Biomedical;
two
industrial
technology
businesses:
Surface
Engineered
Products
and
Aerospace
Products;
two
industrial
products
businesses:
Coinage
and
Chemicals.
For
the
three
months
ended
3/31/01,
revenues
fell
37%
to
$21.1
million.
Net
loss
from
continuing
operations
totaled
$8
million
vs.
an
income
of
$1.5
million.
Results
reflect
decreased
sale
of
the
Acticoat
product
and
the
absence
of
a
$10.5
million
minority
sale. Recent Earnings Announcement For
the
3
months
ended
06/30/2001,
revenues
were
16,215;
after
tax
earnings
were
2,018. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| Officers | |
| Position | Ian Delaney | Chairman | Kevin Jenkins | Pres,
CEO, Director | G.A. Fitch | CFO,
Exec. VP | Scott Gillis | Pres,
Westaim Biomedical Corp. | Michael Goldstein | Pres,
iFire Technology Inc. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|